RxDoctor Payments Data

Jordan Frye, PA

Physician Assistant · Yuma, AZNPI 1184263717

Payments from drug & device makers

$1,038in general payments, 2019–2025

Across 45 payments — averaging $23.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$545
  • Johnson & Johnson$151
  • Regeneron Healthcare Solutions, Inc.$80
  • Sanofi$46
  • Takeda Pharmaceuticals U.S.A., Inc.$45
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$44
  • plus $128 from 6 others

What the payments were for

  • Food & beverage$96293%
  • Education$767%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,038 in reported general payments places this provider in the 70th percentile of 2,888 physician assistant providers in Arizona.

See all physician assistant providers in Arizona

Medicare billing

Part B allowed, 2024
$94,828
Medicare patients
661
Services billed
907

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
StelaraUstekinumab17$426,223
XifaxanRifaximin17$45,428
CreonLipase/Protease/Amylase39$37,198
ZenpepLipase/Protease/Amylase34$23,798
LinzessLinaclotide33$22,599
MovantikNaloxegol Oxalate21$10,636
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates73$4,736
Budesonide EcBudesonide12$3,199
Esomeprazole Magnesium29$3,024
Cholestyramine LightCholestyramine34$2,707
Ursodiol11$2,356
Lubiprostone11$2,299
Omeprazole147$2,221
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl142$1,955
Pantoprazole Sodium103$1,597

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonStelara$151$426,22317 claims
AbbVieCreon, Linzess$545$59,79672 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$44$45,42817 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,888 physician assistant providers in Arizona.

Other physician assistant in Yuma

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →